Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Zonnenberg

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Clinical Endocrinology|July 12, 2008
Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcomeC R C Pieterman, J M J Schreinemakers, H P F Koppeschaar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade gliomaT J Postma, J J Heimans, S A Luykx, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet countsJ M de Klerk, E B van Dieren, A D van het Schip, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone painJ M Quirijnen, S H Han, B A Zonnenberg, et al.
Neurology|November 23, 2007
Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutationsF E Jansen, O Braams, K L Vincken, et al.
Neurology|November 23, 2007
Cognitive impairment in tuberous sclerosis complex is a multifactorial conditionF E Jansen, K L Vincken, A Algra, et al.
European Radiology|November 8, 2008
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysisM A D Vente, M Wondergem, I van der Tweel, et al.
American Journal of Human Genetics|May 20, 1999
High rate of mosaicism in tuberous sclerosis complexS Verhoef, L Bakker, A M Tempelaars, et al.
Neurology|October 22, 1998
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology GroupM J van den Bent, J M Kros, J J Heimans, et al.
EJNMMI Research|December 23, 2016
Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment responseC E N M Rosenbaum, A F van den Hoven, M N G J A Braat, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Clinical Endocrinology|July 12, 2008
Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcomeC R C Pieterman, J M J Schreinemakers, H P F Koppeschaar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2000
A phase II study of paclitaxel in chemonaïve patients with recurrent high-grade gliomaT J Postma, J J Heimans, S A Luykx, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet countsJ M de Klerk, E B van Dieren, A D van het Schip, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone painJ M Quirijnen, S H Han, B A Zonnenberg, et al.
Neurology|November 23, 2007
Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutationsF E Jansen, O Braams, K L Vincken, et al.
Neurology|November 23, 2007
Cognitive impairment in tuberous sclerosis complex is a multifactorial conditionF E Jansen, K L Vincken, A Algra, et al.
European Radiology|November 8, 2008
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysisM A D Vente, M Wondergem, I van der Tweel, et al.
American Journal of Human Genetics|May 20, 1999
High rate of mosaicism in tuberous sclerosis complexS Verhoef, L Bakker, A M Tempelaars, et al.
Neurology|October 22, 1998
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology GroupM J van den Bent, J M Kros, J J Heimans, et al.
EJNMMI Research|December 23, 2016
Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment responseC E N M Rosenbaum, A F van den Hoven, M N G J A Braat, et al.
Pageof 5